Bone loss and fracture after lung transplantation

Transplantation

Volumn 68, Issue 2, 1999, Pages 220-227

  Shane, Elizabeth ^a   Papadopoulos, Anastasio ^a   Staron, Ronald B ^a   Addesso, Vicki ^a   Donovan, Daniel ^a   McGregor, Carlton ^a   Schulman, Larry L ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; CALCITONIN; CALCIUM; CYCLOSPORIN; ESTROGEN; ETIDRONIC ACID; METHYLPREDNISOLONE; MULTIVITAMIN; OKT 3; PAMIDRONIC ACID; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VITAMIN D;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE MINERALIZATION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; FEMUR NECK; FRACTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LUMBAR SPINE; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BONE DENSITY; BONE RESORPTION; CALCITONIN; DIPHOSPHONATES; ESTROGENS; FEMALE; FRACTURES, BONE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOPOROSIS; POSTOPERATIVE CARE; TIME FACTORS;

EID: 0033609512     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199907270-00010     Document Type: Article

References (46)

1. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.
2. Epstein S, Shane E. Transplantation osteoporosis. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. New York: Academic Press, 1996: 947.
3. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med 1998; 104: 459.
4. Ferrari SL, Nicod LP, Hamacher J, et al. Osteoporosis in patients undergoing lung transplantation. Eur Respir J 1996; 9: 2378.
5. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest 1996; 109: 1176.
6. Schulman L, Addesso V, Staron RB, Shane E. Sacral insufficiency fracture after lung transplantation. J Heart Lung Transplant 1997; 16: 1081.
7. Shane E, Silverberg SJ, Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996; 101: 262.
8. Kanis JA, Melton, LJ, Christiansen C, Johnston CC, Khaltaev N. Perspective: the diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137.
9. Shane E, Rivas M, McMahon DJ, et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 1997; 82: 1497.
10. Shane E, Rivas M, Staron RB, et al. Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 1996; 81: 1740.
11. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997; 103: 197.
12. Looker AC, Wahner HW, Dunn WL, et al. Proximal femur bone mineral levels of US adults. Osteoporosis Int 1995; 5: 385.
13. Rizzoli R, Slosman D, Bonjour J-Ph. The role of dual energy x-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis. Am J Med 1995; 98 (suppl 2A): 33.
14. Eastell R, Dickson ER, Hodgson SF, et al. Rates of bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatol 1991; 14: 296.
15. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents on the skeleton. J Bone Miner Res 1996; 11: 1.
16. Lukert BP. Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. New York: Academic Press, 1996: 801.
17. Lukert B, Kream BE. Clinical and basic aspects of glucocorticoid action in bone. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. New York: Academic Press, 1996: 533.
18. Reid IR, Ibbotson HK. Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 1986; 44: 287.
19. Ringe JD, Wetzel D. Salmon calcitonin in the therapy of corticosteroid-induced osteoporosis. Eur J Clin Pharmacol 1987; 33: 35.
20. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidine)-1,1-bisphosphonate (APD). Lancet 1988; 1: 143.
21. Grecu EO, Weinshelbaum A, Simmons R. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate. Calcif Tissue Int 1990; 46: 194.
22. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991; 49: 71.
23. Lukert B, Johnson BE, Robinson RG. Estrogen and progesterone replacement reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992; 7: 1063.
24. Mulder H, Struys A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol 1994; 33: 348.
25. Luengo M, Pons F, Martinez de Osaba MJ, Picado C. Prevention of further bone loss by calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow-up study. Thorax 1994; 49: 1099.
26. Diamond T, McGiugan L, Barbagalla S, Bryant C. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. Am J Med 1995; 98: 459.
27. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382.
28. Reid IR. Preventing glucocorticoid-induced osteoporosis. N Engl J Med 1997; 337: 420.
29. Saag K, Emkey R, Gruber B, et al. Alendronate for the management of glucocorticoid-induced osteoporosis: results of a multicenter U.S. study. Arthritis Rheum 1997; 40 (suppl): S136.
30. Shane E, Rodino M, McMahon D, et al. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant 1988; 17: 1089.
31. Shane E, Rodino M, Thys-Jacobs S, et al. Comparison of two antiresorptive regimens on rates of bone loss after cardiac transplantation [Abstract]. J Bone Miner Res 1997; 12: S181.
32. Fan S, Almond MK, Ball E, Evans K, Cunningham J. Randomized prospective study demonstrating prevention of bone loss by pamidronate during the first year after renal transplantation [Abstract]. J Am Soc Nephrol 1996; 7: A2714.
33. Valero MA, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 1995; 57: 15.
34. Van Cleemput J, Daenen W, Geusens P, Dequeker J, Van de Werf F, Vanhaecke J. Prevention of bone loss in cardiac transplant recipients: a comparison of biphosphonates and vitamin D. Transplantation. 1996; 61: 1495.
35. McDonald JA, Dunstan CR, Dilworth P, et al. Bone loss after liver transplantation. Hepatology 1991; 14: 613.
36. Meys E, Fontanges E, Fourcade N, et al. Bone loss after orthotopic liver transplantation. Am J Med 1994; 97: 445.
37. Navasa M, Monegal A, Guanabens N, et al. Bone fractures in liver transplant patients. Br J Rheumatol 1994; 33: 52.
38. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral bone density after renal transplantation. N Engl J Med 1991; 325: 544.
39. Horber FF, Casez JP, Steiger U, Czerniak A, Montandon A, Jaeger PH. Changes in bone mass early after kidney transplantation. J Bone Miner Res 1994; 9: 1.
40. Sambrook PN, Kelly PJ, Keogh A, et al. Bone loss after cardiac transplantation: a prospective study. J Heart Lung Transplant 1994; 13: 116.
41. Donovan DS, Papadopoulos A, Staron RB, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 1998; 157: 1892.
42. Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995; 54: 801.
43. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocrine Rev 1993; 14: 690.
44. Lane NE, Thompson JM, Modin G, Sanchez S, Arnaud C. Can parathyroid hormone treatment reverse steroid osteoporosis: preliminary results of biochemical markers and bone density. J Bone Miner Res 1997; 12 (suppl 1): S130.
45. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Effects of calcium, Calderol and monofluorophosphate on lumbar bone mass and parathyroid function in patients after cardiac transplantation. Osteoporosis Int 1993; 3: 329.
46. Johannson AG, Rosen CJ. The IGFs as potential therapy for metabolic bone diseases. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. New York: Academic Press, 1996: 1099.